Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.
Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Genfit, explained in plain language.
This study tests a new combination of two drugs, GNS561 and trametinib, in people with advanced bile duct cancer that has a specific genetic change called a KRAS mutation. The cancer must have worsened after at least one round of standard chemotherapy. The goal is to see if the c…
Phase: PHASE1, PHASE2 • Sponsor: Genfit • Aim: Disease control
Last updated Apr 26, 2026 19:35 UTC